EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trophoblast Extracellular Vesicles Rewire Immunity: A Symptom‐Relief Avenue for Recessive Dystrophic Epidermolysis Bullosa

Nell Hirt, Enzo Manchon, Ming Wu, Helene Le Buanec, Pauline Bataille, Emmanuelle Bourrat, Jean-David Bouaziz, Nabila Jabrane-Ferrat iD, Reem Al-Daccak

Journal of Extracellular Vesicles · 2026

DOI: 10.1002/jev2.70315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Nell Hirt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Saint Louis Research Institute, Saint-Louis Hospital, University of Paris, INSERM, CNRS, IRSL, Paris, France. Hauptthemen laut MEDLINE: Extracellular Vesicles, Epidermolysis Bullosa Dystrophica, Trophoblasts. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Société Française de Dermatologie, Fondation d'Avenir, Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Redirecting immune responses toward tissue repair represents a promising strategy for treating inflammatory and degenerative diseases. Extracellular vesicles (EVs), derived from allogeneic stem cells, have shown potential for modulating proinflammatory immunity. Among these, placental‐derived EVs (PEVs) are emerging as candidates for immune‐mediated inflammatory disorders due to their role in establishing maternal immune tolerance. However, their applicability beyond pregnancy remains limited by key translational barriers, including the lack of a standardized and scalable source system and need to demonstrate immunomodulatory activity in non‐pregnancy allogeneic contexts. In this study, we identify extravillous trophoblasts (EVTs), which play critical role in early placental development, as key source of immunoregulatory PEVs. To overcome donor variability, we employed the HIPEC cell model as established surrogate for primary EVTs and assessed the effects of their derived EVs (EVT‐EVs) on circulating monocytes, pivotal mediators of inflammatory responses. High‐dimensional molecular profiling revealed that EVT‐EVs, similar to EVs derived from first‐trimester primary human trophoblast, carry a distinctive anti‐inflammatory signature, including a unique miRNA repertoire enriched in immunoregulatory pathways. Integrated proteomic and lipidomic analyses demonstrated that EVT‐EVs induce coordinated functional reprograming of monocytes toward an immunomodulatory, inflammation‐resolving phenotype. Notably, EVT‐EVs also modulated the inflammatory bias of monocytes from patients with recessive dystrophic epidermolysis bullosa (RDEB), a genetic disorder characterized by chronic inflammation, thereby promoting restoration of immune balance. Collectively, these findings identify EVT‐EVs as a scalable, off‐the‐shelf platform with high translational potential for the treatment of chronic inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesEpidermolysis Bullosa DystrophicaTrophoblastsHumansFemalePregnancyExtravillous TrophoblastsInflammationMonocytesPlacenta

Stichwörter der Autor:innen

Inflammationextracellular vesiclesextravillous trophoblastsmonocytesrecessive dystrophic epidermolysis bullosa

Autor:innen und Institutionen

  • Saint Louis Research Institute, Saint-Louis Hospital, University of Paris, INSERM, CNRS, IRSL, Paris, France.
  • Infinity-Institute for Infectious and Inflammatory Diseases, University of Toulouse, CNRS, INSERM, Toulouse, France.
  • AP-HP, Department of Dermatology, Saint-Louis Hospital, Paris, France.

ORCID-Profile: Nabila Jabrane-Ferrat

Förderung

  • Société Française de Dermatologie
  • Fondation d'Avenir
  • Fondation pour la Recherche Médicale
  • Inserm
  • Inserm-CNRS-University of Toulouse
  • Société Française de Dermatologie et de Pathologie Sexuellement Transmissible
  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Hirt, N., Manchon, E., Wu, M., Buanec, H. L., Bataille, P., Bourrat, E., Bouaziz, J. D., Jabrane-Ferrat, N., & Al-Daccak, R. (2026). Trophoblast Extracellular Vesicles Rewire Immunity: A Symptom‐Relief Avenue for Recessive Dystrophic Epidermolysis Bullosa. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70315

Vancouver

Hirt N, Manchon E, Wu M, Buanec HL, Bataille P, Bourrat E, et al. Trophoblast Extracellular Vesicles Rewire Immunity: A Symptom‐Relief Avenue for Recessive Dystrophic Epidermolysis Bullosa. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70315

BibTeX
@article{Hirt2026,
  author = {Hirt, Nell and Manchon, Enzo and Wu, Ming and Buanec, Helene Le and Bataille, Pauline and Bourrat, Emmanuelle and Bouaziz, Jean-David and Jabrane-Ferrat, Nabila and Al-Daccak, Reem},
  title = {Trophoblast Extracellular Vesicles Rewire Immunity: A Symptom‐Relief Avenue for Recessive Dystrophic Epidermolysis Bullosa},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  doi = {10.1002/jev2.70315}
}
Kostenlos starten →